Filing Details
- Accession Number:
- 0001104659-23-073229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-21 10:57:15
- Reporting Period:
- 2023-06-09
- Accepted Time:
- 2023-06-21 10:57:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1508381 | Bionik Laboratories Corp. | BNKL | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 271340346 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1716639 | Remi Gaston-Dreyfus | C/O Bionik Laboratories Corp. 80 Coolidge Hill Road Watertown MA 02472 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2023-06-09 | 180,555 | $0.60 | 1,814,871 | No | 4 | P | Indirect | Shares held through GD Holdings and Lombard International Assurance SA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Shares held through GD Holdings and Lombard International Assurance SA |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | 61,256 | Direct |
Footnotes
- The reporting person acquired the shares of common stock in lieu of cash payment of $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.
- Includes 17,476 exchangeable shares of the Issuer's subsidiary.
Billionaire Hedge Funds
